AI
| Followers | 843 |
| Posts | 122891 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Sunday, February 11, 2007 10:04:40 PM
HCV Treatment Evolution 1989-2015
Two aspects of this graphic stand out:
1) Peg-interferon will hang around for
another decade or so; and 2) Regimens
including two or more direct antiviral agents
will not be part of the SoC until 2011
because it will be difficult for companies
to run clinical trials on combinations of
unapproved drugs.
Source of graphic: Idenix
Two aspects of this graphic stand out:
1) Peg-interferon will hang around for
another decade or so; and 2) Regimens
including two or more direct antiviral agents
will not be part of the SoC until 2011
because it will be difficult for companies
to run clinical trials on combinations of
unapproved drugs.
Source of graphic: Idenix
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
